1
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Morgan KA: Current controversies in cancer
care for the surgeon. Springer; 2016, View Article : Google Scholar
|
4
|
Soares FA, Coimbra FJ, Pelosof AG, Freitas
HC, Begnami MD, Costa Jr WL, Fannelli MF, Lopes de Mello CA, morim
M, Pizzi MP, et al: Genomics and epidemiology for gastric
adenocarcinomas. Appl Cancer Res. 37:72017. View Article : Google Scholar
|
5
|
Rugge M, Fassan M and Graham DY:
Epidemiology of gastric cancer. Gastric Cancer. Springer; pp.
23–34. 2015, View Article : Google Scholar : PubMed/NCBI
|
6
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Bushati N and Cohen SM: microRNA
functions. Ann Rev Cell Dev Bio. 23:175–205. 2007. View Article : Google Scholar
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Li Q, Li J, Dai W, Li YX and Li YY:
Differential regulation analysis reveals dysfunctional regulatory
mechanism involving transcription factors and microRNAs in gastric
carcinogenesis. Artif Intell Med. 77:12–22. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mirghasemi A, Taheriazam A, Karbasy SH,
Torkaman A, Shakeri M, Yahaghi E and Mokarizadeh A: Retraction
Note: Down-regulation of miR-133a and miR-539 are associated with
unfavorable prognosis in patients suffering from osteosarcoma.
Cancer Cell Int. 16:842016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhu C, Zhou R, Zhou Q, Chang Y and Jiang
M: microRNA-539 suppresses tumor growth and tumorigenesis and
overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Life Sci. 166:34–40. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lv LY, Wang YZ, Zhang Q, Zang HR and Wang
XJ: miR-539 induces cell cycle arrest in nasopharyngeal carcinoma
by targeting cyclin-dependent kinase 4. Cell Biochem Funct.
33:534–540. 2015. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Retraction, ; Xianzheng Gao, Shenglei Li,
Wencai Li, Guannan Wang, Wugan Zhao, Jing Han, Changying Diao,
Xiaohui Wang and Mingzhi Zhang: MicroRNA-539 suppresses tumor cell
growth by targeting the WNT8B gene in non-small cell lung cancer.
J. Cell. Biochem. Accepted Article doi.org/10.1002/jcb.26634. J
Cell Biochem. Dec 21–2017.(Epub ahead of print).
|
14
|
Gu L and Sun W: MiR-539 inhibits thyroid
cancer cell migration and invasion by directly targeting CARMA1.
Biochem Biophys Res Commun. 464:1128–1133. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Chen GD and Liu YL: Clinical, endoscopic
and pathologic analysis of 36 cases of early gastric cancer. China
J Endosc. 2012:(In Chinese).
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Singh S and Jha HC: Status of epstein-barr
virus coinfection with Helicobacter pylori in gastric
cancer. J Oncol. 2017:34562642017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jin H and Wang W: MicroRNA-539 suppresses
osteosarcoma cell invasion and migration in vitro and targeting
Matrix metallopeptidase-8. Int J Clin Exp Pathol. 8:8075–8082.
2015.PubMed/NCBI
|
19
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Pei XH, Lv XQ and Li HX: Sox5 induces
epithelial to mesenchymal transition by transactivation of Twist1.
Biochem Biophys Res Commun. 446:322–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang D and Liu S: SOX5 promotes
epithelial-mesenchymal transition in osteosarcoma via regulation of
Snail. J BUON. 22:258–264. 2017.PubMed/NCBI
|